A Comparison of PF708 and Forteo in Osteoporosis Patients
Public ClinicalTrials.gov record NCT03002428. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Study Comparing the Effects of PF708 and Forteo in Patients With Osteoporosis
Study identification
- NCT ID
- NCT03002428
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfenex, Inc
- Industry
- Enrollment
- 181 participants
Conditions and interventions
Conditions
Interventions
- Teriparatide (PF708) Drug
- Teriparatide (Forteo) Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- Apr 30, 2018
- Completion
- Apr 30, 2018
- Last update posted
- May 22, 2018
2016 – 2018
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research | Birmingham | Alabama | 35211 | — |
| The Orthopaedic Group | Mobile | Alabama | 36608 | — |
| Radiant Research | Chandler | Arizona | 85224 | — |
| Radiant Research | Mesa | Arizona | 85213 | — |
| SunValley Arthritis Center | Peoria | Arizona | 85381 | — |
| Radiant Research | Phoenix | Arizona | 85020 | — |
| Radiant Research | Colorado Springs | Colorado | 80909 | — |
| OB-GYN Associates of Mid-Florida | Leesburg | Florida | 34748 | — |
| Atlanta Research Center | Atlanta | Georgia | 30319 | — |
| Radiant Research | Chicago | Illinois | 60602 | — |
| Radiant Research | Bridgeton | Missouri | 63044 | — |
| Radiant Research | Papillion | Nebraska | 68046 | — |
| Radiant Research | Henderson | Nevada | 89074 | — |
| Radiant Research | Las Vegas | Nevada | 89128 | — |
| New Mexico Clinical Research & Osteoporosis Center | Albuquerque | New Mexico | 87106 | — |
| Lillestol Research | Fargo | North Dakota | 58103 | — |
| Radiant Research | Akron | Ohio | 44311 | — |
| Radiant Research | Cincinnati | Ohio | 45236 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Pennsylvania Regional Center for Arthritis & Osteoporosis Research | Wyomissing | Pennsylvania | 19610 | — |
| Radiant Research | Dallas | Texas | 75231 | — |
| Radiant Research | Plano | Texas | 75093 | — |
| Radiant Research | San Antonio | Texas | 78229 | — |
| Radiant Research | San Antonio | Texas | 78240 | — |
| Spectrum Medical | Danville | Virginia | 24541 | — |
| Radiant Research | Puyallup | Washington | 98372 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03002428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2018 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03002428 live on ClinicalTrials.gov.